openPR Logo

Press Releases from DelveInsight Business Research LLP (4878 total)

Diffuse Large B-Cell Lymphoma Clinical Trials | A Drug Pipeline Analysis Report …

United States, Nevada, Las Vegas, DelveInsight's 'Diffuse Large B-Cell Lymphoma Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diffuse Large

Dermatomyositis Clinical Trials | A Drug Pipeline Analysis Report 2024 | Corbus …

United States, Nevada, Las Vegas, DelveInsight's 'Dermatomyositis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Dermatomyositis therapies in various stages

Hypofibrinogenemia Pipeline Therapeutics Assessment Report 2024

DelveInsight's, "Hypofibrinogenemia Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Hypofibrinogenemia pipeline landscape. It covers the pipeline drug

Desmoid Tumors Clinical Trials | A Drug Pipeline Analysis Report 2024 | SpringWo …

United States, Nevada, Las Vegas, DelveInsight's 'Desmoid Tumors Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Desmoid Tumors therapies in

Idiopathic Pulmonary Fibrosis Pipeline Therapeutics Assessment Report 2024 (Upda …

DelveInsight's, "Idiopathic Pulmonary Fibrosis Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Idiopathic Pulmonary Fibrosis pipeline landscape. It

Interstitial Cystitis Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Interstitial Cystitis Pipeline Insight 2024" report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Interstitial Cystitis pipeline landscape. It covers the

Irritable Bowel Syndrome Market Size in the 7MM is expected to grow by 2034, est …

DelveInsight's "Irritable Bowel Syndrome Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Irritable Bowel Syndrome, historical and forecasted

Primary Sclerosing Cholangitis Pipeline Therapeutics Assessment Report 2024

DelveInsight's, "Primary Sclerosing Cholangitis Pipeline Insight 2024" report provides comprehensive insights about 14+ companies and 14+ pipeline drugs in Primary Sclerosing Cholangitis pipeline landscape. It

Psoriasis Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Psoriasis Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Psoriasis pipeline landscape. It covers the pipeline drug

Psoriatic Arthritis Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Psoriatic Arthritis Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Psoriatic Arthritis pipeline landscape. It covers the

Acne Vulgaris Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Acne Vulgaris Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Acne Vulgaris pipeline landscape. It covers the

Breast Cancer Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 120+ Breast Cancer companies and 130+ pipeline drugs in the Breast Cancer pipeline landscape.

Small Cell Lung Cancer Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Small Cell Lung Cancer Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Small Cell Lung Cancer pipeline

Complex Regional Pain Syndrome Pipeline Therapeutics Assessment 2024 (Updated)

DelveInsight's, "Complex regional pain syndromes Pipeline Insight 2024" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Complex regional pain syndromes pipeline

Complement 3 Glomerulopathy Pipeline Therapeutics Assessment Report 2024

DelveInsight's, "Complex regional pain syndromes Pipeline Insight, 2024" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Complex regional pain syndromes pipeline

Glaucoma Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Glaucoma Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Glaucoma pipeline landscape. It covers the pipeline drug

Geographic Atrophy Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Geographic Atrophy Pipeline Insight 2024" report provides comprehensive insights about 23+ companies and 25+ pipeline drugs in Geographic Atrophy pipeline landscape. It covers the

Herpes Zoster Pipeline Therapeutics Assessment 2024 (Updated)

DelveInsight's, "Herpes Zoster Pipeline Insight 2024," report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Herpes Zoster pipeline landscape. It covers the

Hidradenitis Suppurativa Pipeline Therapeutics, Assessment, Companies, Products, …

DelveInsight's, "Hidradenitis Suppurativa Pipeline Insight 2024" report provides comprehensive insights about 24+ companies and 24+ pipeline drugs in Hidradenitis Suppurativa pipeline landscape. It covers the

Hunter Syndrome Pipeline Therapeutics, Assessment, Companies, Products, Unmet Ne …

DelveInsight's, "Hunter Syndrome Pipeline Insight, 2024," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Hunter Syndrome pipeline landscape. It covers the

Amyotrophic Lateral Sclerosis Pipeline Insights and Treatment Drugs 2024 (Update …

DelveInsight's, "Amyotrophic Lateral Sclerosis Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Amyotrophic Lateral Sclerosis pipeline landscape. It

Psoriatic Arthritis Pipeline Insights and Treatment Drugs 2024 (Updated)

DelveInsight's, "Psoriatic Arthritis Pipeline Insight 2024" report provides comprehensive insights about 50+ Psoriatic Arthritis companies and 50+ pipeline drugs in the Psoriatic Arthritis pipeline landscape.

Chronic Rhinosinusitis with Nasal Polyps Pipeline Insights and Treatment Drugs 2 …

DelveInsight's, "Chronic Rhinosinusitis with Nasal Polyps Pipeline Insight, 2024," report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Chronic Rhinosinusitis with Nasal

Netherton Syndrome Pipeline, Therapeutics Assessment, Clinical Trials, Drugs, an …

DelveInsight's, "Netherton Syndrome Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Netherton Syndrome pipeline landscape. It covers the

Non Cystic Fibrosis Bronchiectasis Pipeline, Therapeutics Assessment, Clinical T …

DelveInsight's, "Non‐cystic fibrosis bronchiectasis Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Non‐cystic fibrosis bronchiectasis pipeline landscape. It

Obstructive Sleep Apnea Pipeline, Therapeutics Assessment, Clinical Trials, Drug …

DelveInsight's, "Obstructive Sleep Apnea Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 21+ pipeline drugs in Obstructive Sleep Apnea (OSA) pipeline landscape.

Postherpetic Neuralgia Pipeline, Therapeutics Assessment, Clinical Trials, Drugs …

DelveInsight's, "Postherpetic Neuralgia Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Postherpetic Neuralgia pipeline landscape. It covers the

Biopsy Devices Pipeline Insight and Competitive Landscape 2023 | Biopsy Devices …

DelveInsight's "Biopsy Devices - Pipeline Insight and Competitive Landscape 2023," report provides comprehensive insights about 20+ companies and 23+ pipeline devices in the biopsy devices

Infliximab Biosimilar Insights Report 2023 by DelveInsight | Celltrion, Pfizer, …

DelveInsight's "Infliximab Biosimilar Insight, 2023" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the

Eosinophilic Asthma Market to Show a Rise During the Study Period | Teva Pharmac …

DelveInsight's "Eosinophilic Asthma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Eosinophilic Asthma, historical and forecasted epidemiology as well as

Cushing's Syndrome Market to Show a Rise During the Study Period | Corcept Thera …

DelveInsight's "Cushing's Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Cushing's Syndrome, historical and forecasted epidemiology as well as

Functional Dyspepsia Market to Show a Rise During the Study Period | Takeda Phar …

DelveInsight's "Functional Dyspepsia Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Functional Dyspepsia, historical and forecasted epidemiology as well as

Ependymoma Market to Show a Rise During the Study Period | Fera Pharmaceuticals, …

DelveInsight's "Ependymoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Ependymoma, historical and forecasted epidemiology as well as the Ependymoma

Typhoid Fever Market to Show a Rise During the Study Period | Teva Pharmaceutica …

DelveInsight's "Typhoid Fever Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Typhoid Fever, historical and forecasted epidemiology as well as

Hyperlipidemia Market to Show a Rise During the Forecast Period | Merck & Co., S …

DelveInsight's "Hyperlipidemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hyperlipidemia, historical and forecasted epidemiology as well as the Hyperlipidemia

Mammography Devices Market Insight & Forecast by DelveInsight

The global market for mammography devices reached a value of USD 1.78 billion in 2020 and is projected to grow at a CAGR of 9.15%

Clear Cell Carcinoma Market to Show a Rise During the Study Period |F. Hoffmann- …

DelveInsight's "Clear Cell Carcinoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Clear Cell Carcinoma, historical and forecasted epidemiology as

Chronic Liver Disease Market to Show a Rise During the Study Period | Abbott Lab …

DelveInsight's "Chronic Liver Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Liver Disease, historical and forecasted epidemiology as

Chronic Hemodialysis Market to Show a Rise During the Study Period | Fresenius M …

DelveInsight's "Chronic Hemodialysis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Hemodialysis, historical and forecasted epidemiology as well as

Chronic Brain Damage Market to Show a Rise During the Study Period | NeuroVive P …

DelveInsight's "Chronic Brain Damage Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Brain Damage, historical and forecasted epidemiology as

Chiari Malformation Market to Show a Rise During the Study Period | Pfizer Inc., …

DelveInsight's "Chiari Malformation Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chiari Malformation, historical and forecasted epidemiology as well as

Chemotherapy-induced Hearing Loss Market to Show a Rise During the Study Period …

DelveInsight's "Chemotherapy-induced Hearing Loss Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chemotherapy-induced Hearing Loss, historical and foreacasted epidemiology as

Postpartum Depression Pipeline Therapeutics, Assessment, Companies, Products, Un …

DelveInsight's, "Postpartum Depression Pipeline Insights 2024" report provides comprehensive insights about 2+ companies and 2+ pipeline drugs in the Postpartum Depression pipeline landscape. It covers

Presbyopia Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, …

DelveInsight's, "Presbyopia Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Presbyopia pipeline landscape. It covers the pipeline drug

Primary Biliary Cholangitis Pipeline Therapeutics, Assessment, Companies, Produc …

DelveInsight's, "Primary Biliary Cholangitis Pipeline Insight 2024" report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Primary Biliary Cholangitis pipeline landscape. It

Primary Hyperoxyaluria Pipeline Therapeutics, Assessment, Companies, Products, U …

DelveInsight's, "Primary Hyperoxyaluria Pipeline Insight 2024" report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Primary Hyperoxyaluria pipeline landscape. It covers the

Stargardt Disease Pipeline Therapeutics, Assessment, Companies, Products, Unmet …

DelveInsight's, "Stargardt Disease Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Stargardt Disease (STGD) pipeline landscape. It covers

Surgical Site Infection Pipeline Therapeutics, Assessment, Companies, Products, …

DelveInsight's, "Surgical Site Infection Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Surgical Site Infection pipeline landscape. It

Synovial Sarcoma Pipeline Therapeutics, Assessment, Companies, Products, Unmet N …

DelveInsight's, "Synovial Sarcoma Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Synovial-Sarcoma pipeline landscape. It covers the pipeline

Systemic Lupus Erythematosus Pipeline Therapeutics, Assessment, Companies, Produ …

DelveInsight's, "Systemic Lupus Erythematosus Pipeline Insight 2024" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in the Systemic Lupus Erythematosus pipeline landscape.

Go To Page:    31 32 33 34 35 36 37 38 39 40